New Residential Investment Price Target & Analyst Ratings (NYSE:NRZ)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

6 Wall Street analysts have issued ratings and price targets for New Residential Investment in the last 12 months. Their average twelve-month price target is $17.90, suggesting that the stock has a possible upside of 15.93%. The high price target for NRZ is $19.00 and the low price target for NRZ is $16.00. There are currently 6 buy ratings for the stock, resulting in a consensus rating of "Buy."

New Residential Investment (NYSE:NRZ) Consensus Price Target History

New Residential Investment (NYSE:NRZ) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
10/4/2019	Piper Jaffray Companies	Lower Price Target	Overweight	$18.00 ➝ $16.00	Low
9/6/2019	BTIG Research	Initiated Coverage	Buy	$18.00 ➝ $18.00	Medium
8/29/2019	B. Riley	Set Price Target	Buy	$19.00	Low
8/19/2019	Wedbush	Reiterated Rating	Outperform		Low
3/27/2019	Nomura	Initiated Coverage	Buy	$18.50	Low
1/4/2019	Credit Suisse Group	Reiterated Rating	Buy	$18.00	Low
10/5/2018	Raymond James	Initiated Coverage	Outperform ➝ Outperform	$20.00	Low
7/25/2018	Barclays	Boost Price Target	Overweight ➝ Overweight	$19.00 ➝ $21.00	Low
10/30/2017	FBR & Co	Reiterated Rating	Buy	$19.25	N/A

(Data available from 10/16/2017 forward)